Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC — Stella

Home/Leukemia/Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC

View on ClinicalTrials.gov

Recruiting

Back to Leukemia trials

Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

United States

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Key details

Phase

Very early testing

Sponsor

Children's Hospital of Philadelphia

Enrollment target

~100 participants

Started

December 2013

Primary completion

January 2027

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.